30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

2Q14 Revenue: Bacterin

$8.9MM, +8%

  • Estimates 2014 U.S. knee and ankle microfracture procedures of ~410,000; shows promise for distribution channel
  • Claims 6.5% U.S. market share in DBM behind Medtronic, DePuy and Integra
  • ~2/3 of revenue arises from spinal fusion
  • ~100 active manufacturers’ reps, planning to end year at 140